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Background/Aims
A self-report questionnaire is frequently used to measure symptoms reliably and to distinguish patients with functional gastro-
intestinal disorders (FGIDs) from those with other conditions. We produced and validated a cross-cultural adaptation of the 
Rome III questionnaire for diagnosis of FGIDs in Korea.
Methods
The Korean version of the Rome III (Rome III-K) questionnaire was developed through structural translational processes. 
Subsequently, reliability was measured by a test-retest procedure. Convergent validity was evaluated by comparing self-reported 
questionnaire data with the subsequent completion of the questionnaire by the physician based on an interview and with the 
clinical diagnosis. Concurrent validation using the validated Korean version of the Short Form-36 Health Survey (SF-36) was 
adopted to demonstrate discriminant validity.
Results
A total of 306 subjects were studied. Test-retest reliability was good, with a median Cronbach’s α value of 0.83 (range, 
0.71-0.97). The degree of agreement between patient-administered and physician-administered questionnaires to diagnose 
FGIDs was excellent; the κ index was 0.949 for irritable bowel syndrome, 0.883 for functional dyspepsia and 0.927 for func-
tional heartburn. The physician’s clinical diagnosis of functional dyspepsia showed the most marked discrepancy with that 
based on the self-administered questionnaire. Almost all SF-36 domains were impaired in participants diagnosed with one of 
these FGIDs according to the Rome III-K.
Conclusions
We developed the Rome III-K questionnaire though structural translational processes, and it revealed good test-retest reliability 
and satisfactory construct validity. These results suggest that this instrument will be useful for clinical and research assessments 
in the Korean population.
(J Neurogastroenterol Motil 2013;19:509-515)
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Introduction
Since the historical meeting of experts in Rome in 1988, sev-
eral revisions have been made to standardize the diagnostic cri-
teria of functional gastrointestinal disorders (FGIDs).1-3 This 
standardization has enabled international comparisons of epi-
demiology, clinical features and clinical outcomes of FGIDs. The 
medical terms of the Rome criteria are in English, and the ma-
jority of self-administered symptom questionnaires are intended 
for use with English-speakers.4 A simple translation of a pub-
lished questionnaire usually fails to contain the original meaning 
because of language and cultural differences.5 Therefore, a sys-
tematic translation and the cross-cultural adaptation process are 
essential for research using questionnaires.6 None of self-ad-
ministered questionnaires related to FGIDs have undergone a 
structural validation study in Korea. Thus, the aim of this study 
was to develop, validate and confirm the reliability of the Korean 
version of the self-administered symptom questionnaire based on 
the Rome III criteria (Rome III-K).
Materials and Methods
Development of the Questionnaire
Stepwise processing was used to develop the Rome III-K. 
First, translation of the Rome III criteria and wording were per-
formed according to guidelines.6,7 Two physicians were involved: 
a native Korean physician with long-term residence in the USA 
(Hong YS) and another Korean gastroenterology-subspecialist 
physician (Jung HK). Based on the comments of Richard Bri-
slin,8 back-translation of the translated draft demonstrated that 
the target version was functionally equivalent to the Rome III. A 
translation committee included the above 2 physicians, a psychol-
ogist experienced in questionnaire-based studies, a teacher of 
Korean and 2 native non-medical people. This committee re-
viewed the translation and back-translation and confirmed that 
the questionnaire drafted was developed at the level of under-
standing of sixth grader in elementary school. Several pre-tests 
with native Korean outpatients provided feedback regarding the 
readability and comprehensibility of the questionnaire to the 
translation committee. After these pilot studies, we compiled the 
final edition of the Rome III-K to be validated. It was composed 
of 35 questions mainly regarding the presence or frequency of 
symptoms, including the diagnosis of irritable bowel syndrome 
(IBS), functional dyspepsia (FD), functional heartburn (FH), 
functional constipation, functional diarrhea and functional 
bloating.
Questionnaire Pilot Study 
The draft of the Rome III-K was tested on patients present-
ing at the gastroenterology clinic of Ewha Womans University, 
Mokdong Hospital. The patients may have complained of gas-
trointestinal symptoms or had no such symptoms. All patients 
were native Korean speakers (age, 33-71 years). Patients were re-
quested to fill out the questionnaire, and one gastroenterology- 
subspecialist judged the FGID clinical diagnosis in a subsequent 
interview with the patient. The agreement between the clinical di-
agnosis and diagnosis based on the self-administered ques-
tionnaire was the key outcome. Tests of feasibility included com-
pleteness of the questionnaire, completion time, length and 
relevance. Feedback from patients on readability was reviewed by 
the translation committee. The translation committee revised the 
questionnaire several times to enhance its comprehensibility.
Validation Study
Participants for the validation study were enrolled from out-
patients visiting gastroenterology clinics. Overall, 5 institutes 
(Ewha Womans University, Mokdong Hospital, Konyang 
University Hospital, Seoul Samsung Medical Center, Gangnam 
Severance Hospital and Seoul Asan Medical Center), 4 located 
in Seoul and one located in Daejeon, were engaged in the survey 
for content validity and reliability. Each institute had 1 gastro-
enterologist who interviewed and examined the patients. 
Recruitment took 7 months from August 2011 to February 2012. 
During the first visit, the participating gastroenterologists in-
ferred whether the patient had minimal comprehensibility to 
complete the questionnaire, and asked the relevant people (age, 
19-70 years) whether they were willing to take the questionnaire. 
Those who provided verbal consent were provided with details of 
the aim and methodology of the study, and gave written consent. 
After the participants completed the questionnaire, the attending 
gastroenterologists, who were blinded to the participants’ re-
sponses, interviewed the participants and subsequently filled out 
the questionnaire. The content validity of the self-administered 
Rome III-K was investigated using the physician-administered 
Rome III-K as the gold standard. The patients may have under-
gone endoscopy or ultrasound before their next visit. However, 
those who had started medical therapy or who already were in the 
course of medications that would affect gastrointestinal symp-
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Table 1. Cronbach’s α Coefficient for Reliability of the Korean 
Version of Rome III Questionnaire for Functional Gastrointestinal
Disorders
Categories of FGIDs Subscales Cronbach’s α
Irritable bowel syndrome Abdominal pain 0.68 (0.55-0.77)
Symptom onset over 
6 months
0.87 (0.81-0.90)
Pain frequency 0.85 (0.80-0.89)
Relieved by 
defecation
0.71 (0.60-0.79)
Increased BM 0.73 (0.63-0.81)
Decreased BM 0.51 (0.33-0.65)
Loose form 0.80 (0.72-0.86)
Hard form 0.65 (0.52-0.75)
Functional dyspepsia Early satiation 0.83 (0.76-0.88)
Symptom onset over 
6 months
0.81 (0.73-0.87)
Postprandial fullness 0.85 (0.80-0.89)
Symptom onset over 
6 months
0.74 (0.64-0.82)
Epigastric pain 0.84 (0.77-0.88)
Symptom onset over 
6 months
0.84 (0.77-0.88)
Severity of pain 0.86 (0.81-0.90)
Intermittent 
symptoms
0.73 (0.63-0.81)
Not relieved by 
defecation
0.60 (0.44-0.71)
Functional heartburn Heartburn 0.82 (0.76-0.87)
Acid regurgitation 0.84 (0.77-0.88)
Symptom onset over 
6 months 
0.75 (0.65-0.82)
Functional constipation BM ＜ 3 per week 0.84 (0.79-0.89)
Lumpy stool 0.77 (0.68-0.83)
Straining 0.83 (0.77-0.88)
Sense of incomplete 
evacuation
0.86 (0.81-0.90)
Sense of blockage 0.78 (0.70-0.84)
Manual Maneuver 0.84 (0.78-0.88)
Symptom onset over 
6 months 
0.73 (0.63-0.81)
Functional diarrhea Loose stool 0.83 (0.77-0.88)
Symptom onset over 
6 months
0.78 (0.70-0.84)
Nausea/Vomiting Nausea 0.83 (0.77-0.88)
Vomiting 0.81 (0.74-0.87)
Functional bloating Bloating 0.89 (0.85-0.92)
The data are presented as medians (95% confidence interval); FGIDs, 
functional gastrointestinal disorders; BM, bowel movement. 
toms were excluded to avoid confounders. Mental health pa-
tients, alcohol or drug abusers, patients suffering from any medi-
cal disease that could affect comprehensibility or readability, such 
as dementia and stroke, were also excluded. The test-retest meth-
od was used to assess reliability of the Rome III-K. The retest was 
the same questionnaire that was completed by the enrolled per-
sons at the second visit, usually 1 week after the first visit. 
Another survey for additional convergent validity and discrim-
inant validity was performed in an independent study population. 
The clinical diagnosis judged by a physician (Jung HK), who 
was blinded to the patients’ responses to the questionnaire, was 
used as the reference to assess convergent validity. We obtained 
responses for the Korean version of Short Form-36 Heath 
Survey questionnaire (SF-36-K) concurrently, which is known to 
be valid and reliable for measuring general health-related quality 
of life (HR-QOL).9 Participants diagnosed with an FGID ac-
cording to the Rome III-K are supposed to have lower HR- 
QOL.10 Therefore, we conducted this concurrent validation to 
assess the validity of the Rome III-K indirectly through the vali-
dated SF-36-K.
Statistical Methods
The majority of Rome III-K question items were categorical 
or dichotomous items, and the test-retest reliability of the Rome 
III-K was assessed by Cronbach’s α coefficient. Coefficient 
＞ 0.7 indicates acceptable consistency. The coefficient for each 
item is presented as a median with a 95% confidence interval. 
Convergent validity was judged with the physician-administered 
questionnaire as the reference. The self-administered ques-
tionnaire and physician-administered questionnaire have the 
same key outcome of the presence or absence of a FGID, which 
can be calculated according to the Rome III criteria. For exam-
ple, we diagnosed IBS if the response of abdominal pain was 
present for the last 3 months (item 1), with a frequency of symp-
toms ＞ 3 days per month (items 1 and 2) associated with 2 or 
more subsets of the following items (items 2-6) ranked ＞ 1, and 
with symptom onset at least 6 months prior to the day of examina-
tion (item 1-1). The overall ratios of agreements for the presence 
of FGIDs between the 2 questionnaires were expressed as a per-
centage and verified using Cohen’s κ coefficient. Convergent val-
idity was expressed as percentage agreement and assessed statisti-
cally using McNemar’s test. Another survey for additional con-
vergent validity was assessed using the clinical diagnosis of a 
physician as the reference value. The Wald- Wolfowitz two-sam-
ple run test was used to determine whether the subjects without or 
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Table 2. Convergent Validity Judged Using a Physician-completed
Questionnaire as the Reference
Participants 
(n)
кa Agreement
(%)
Sensitivity
(%)
Specificity
(%)
Irritable bowel 
syndrome
194 0.94 98.4 97.2 98.7
Functional 
dyspepsia
195 0.88 97.9 94.4 97.7
Functional 
heartburn
196 0.92 97.4 95.4 93.4
Functional 
constipation
196 1.00 100.0 100.0 100.0
Functional 
diarrhea
192 0.85 98.9 75.0 100.0
Functional 
bloating
194 0.96 98.9 97.5 99.3
aP ＜ 0.01 for all, by Cohen’s κ.
Table 3. Convergent Validity Judged Using Clinical Diagnosis as 
the Reference
Participants 
(n)
κa Agreement
(%)
Sensitivity
(%)
Specificity
(%)
Irritable bowel 
syndrome
47 0.18 80.9 77.8 81.6
Functional 
dyspepsia
47 0.45 66.0 70.0 63.0
Functional 
heartburn
47 0.68 87.2 42.9 95.0
aMcNemar’s test verified that the clinical diagnoses by physician and self-diag-
noses based on the Korean version of Rome III questionnaire were not 
significantly different.
with FGIDs had an identical SF-36 score distribution. If the 
overall rate of administered items was ＜ 80% (＜ 28 of 35 ques-
tions), such data were defined as a low responder and excluded 
from any analyses.
Ethical Approval
All institutes engaged in the validation process approved this 
study via their own institutional review boards. All participants 
submitted a written informed consent form at enrollment.
Results
Demographic Characteristics
Overall, 297 subjects agreed to participate inthe reliability 
and content validity survey. Among them, 65 were excluded with 
the response rate of ＜ 80%, a duration too long for the test-re-
test, or dropping out on the second visit.
Finally, 232 subjects were enrolled (median age, 47.5 years; 
range, 19-73 years; male:female, 1:1.7). 
Feasibility
The questionnaire was developed at the sixth grade elemen-
tary school reading level. We measured the time required to com-
plete the Rome III-K in a subset of participants, and the mean 
measured run-time was about 12 minutes (12.0 ± 4.0 minutes).
Reliability
The median visit interval between the test and retest was 7.0 
days (range, 1-19 days). Almost all items had acceptable to ex-
cellent consistency with a Cronbach’s alpha ＞ 0.7 (range, 
0.71-0.97) (Table 1). The median Cronbach’s alpha of all IBS 
items was 0.73 (range, 0.51-0.87), which indicated excellent con-
sistency; FD was 0.84 (range, 0.60-0.86); functional constipation 
was 0.83 (range, 0.73-0.86); functional diarrhea was 0.83; nausea 
was 0.83; vomiting was 0.81; and bloating was 0.89. Four ques-
tions of suboptimal value were related to IBS or FD. One ques-
tion for IBS (features of accompanying decreased bowel move-
ment) and one question regarding FD (epigastric pain not re-
lieved by defecation) showed poor consistency.
Validity 
The degree of agreement between patient-administered and 
physician-administered questionnaires to diagnose FGIDs was 
＞ 95% for all kinds of disorders (Table 2). The κ index of each 
disorder also confirmed that all agreement degrees were signi-
ficant. Subtyping of IBS or FD was accurate. Thirty-six of 194 
participants were diagnosed with IBS in both patient-ad-
ministered and physician-administered questionnaires, and the 
concordance rate of IBS subtyping was as high as 94.4% among 
IBS patients (34/36) (2 diarrhea-predominant patients were clas-
sified as mixed subtype according to the patient-administered 
questionnaire). Subtyping of patients with FD by self-reported 
responses was also highly concordant with the physician-com-
pleted results, as all corresponding patient subtypes were equiv-
alent (17/17). 
We compared the physician’s clinical diagnosis with the 
self-administered responses using a number of subjects (n = 74). 
McNemar’s test verified that there was no significant difference 
for determining the presence or absence of all kinds of FGIDs in 
the population (Table 3). The percentage agreement between 
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Table 5. Short Form-36 Health Survey Scores in Subjects 
Without and With Overlapping Functional Gastrointestinal 
Disorders
SF-36 
domains
Subjects 
without overlap 
(n = 54)
Subjects with 
overlap 
(n = 20)
Z 
score
P-
valuea
Physical functioning 83.6 ± 20.0 85.7 ± 17.0 -6.01 < 0.01
Role-physical 71.2 ± 39.2 63.7 ± 46.9 -7.53 < 0.01
Bodily pain 56.1 ± 27.4 55.3 ± 22.3 -4.82 < 0.01
General health per-
ception
54.7 ± 19.6 47.1 ± 16.5 -3.33 < 0.01
Vitality 49.2 ± 22.8 42.2 ± 17.1 -4.52 < 0.01
Social functioning 86.8 ± 18.7 81.8 ± 16.4 -7.20 < 0.01
Role-emotional 66.0 ± 43.6 55.0 ± 43.6 -7.50 < 0.01
Mental health 66.8 ± 22.2 57.0 ± 18.8 -4.52 < 0.01
SF-36, Short Form-36 Health Survey.
aWald-Wolfowitz two-sample run test.
Table 4. Short Form-36 Health Survey Scores in Subjects Without and With the 3 Functional Gastrointestinal Disorders According to the
Korean Version of Rome III Questionnaire
SF-36 domains Subjects without an FGID (n = 25) IBS (n = 20) FD (n = 16) FH (n = 34)
Physical functioning 81.2 ± 21.0 86.2 ± 14.6a 90.3 ± 21.0a 83.2 ± 20.1a
Role-physical 72.0 ± 37.0 56.2 ± 47.9a 87.5 ± 27.3a 63.9 ± 46.1a
Bodily pain 56.4 ± 25.7 54.4 ± 26.1a 57.3 ± 24.1b 56.2 ± 25.6a
General health perception 53.8 ± 18.1 50.4 ± 21.2a 52.9 ± 18.2a 50.2 ± 18.0a
Vitality 51.2 ± 19.9 42.5 ± 20.9a 44.3 ± 19.6a 46.1 ± 21.7a
Social functioning 89.5 ± 15.1 80.0 ± 8.3a 89.8 ± 12.2a 81.6 ± 20.2a
Role-emotional 82.6 ± 32.0 51.6 ± 46.4a 60.4 ± 40.7a 52.9 ± 46.5a
Mental health 72.9 ± 18.8 58.8 ± 23.1a 57.7 ± 19.3b 59.7 ± 20.7a
SF-36, Short Form-36 Health Survey; IBS, irritable bowel syndrome; FD, functional dyspepsia; FH, functional heartburn.
Wald-Wolfowitz two-sample run test (aP ＜ 0.01 and bP ＜ 0.05).
physicians’ clinical diagnosis and diagnosis by patients’ self-re-
ported questionnaires was excellent: IBS (80.9%), FH (87.2%), 
functional constipation (90.9%), functional diarrhea (95.1%) and 
functional bloating (87.7%). However, a marked discrepancy 
was observed in the diagnosis of FD (34%), although the differ-
ence was not significant.
Rome III-K was sufficiently valid to distinguish patients with 
FGIDs from normal subjects with higher HR-QOL as de-
termined by validation using the SF-36-K. HR-QOL tended to 
be lower in patients suffering from FGIDs compared to that in 
subjects without FGIDs in 7 domains of the SF-36, with the ex-
ception of physical functioning (Table 4). Scores of patients with 
FD did not decline in some additional domains (role physical, 
bodily pain and social functioning). Age, gender ratio and pres-
ence of on-going medical problems were not significantly differ-
ent between the normal group and each FGID; the FH group 
was significantly older than the normal group (52.5 ± 14.0 vs. 
44.0 ± 14.7 years, P = 0.037 by Mann-Whitney test). Similar 
patterns of difference in HR-QOL were also observed when 
subjects with overlapping FGIDs were compared with non-over-
lapping patients. Seven of 8 SF-36 domains were reduced in pa-
tients with overlapping syndromes (Table 5). Age, gender ratio 
and the presence of on-going medical problems were not differ-
ent between the 2 groups.
Discussion
We demonstrated that the Rome III-K is a reliable and valid 
self-reported tool for diagnosis of FGIDs. A validated ques-
tionnaire related to the diagnosis of FGIDs is crucial to assess the 
prevalence of FGIDs in epidemiological studies or to enroll pa-
tients in clinical trials. Systematic translation and independent 
back-translation are essential for accurate translation of the origi-
nal source. Without such processes, cross-language studies are 
vulnerable to the risk that between-group differences, a different 
prevalence for example, are an artifact of differences in the ad-
equacy of translation.5 We produced several reconciled versions 
and a reliable version of the Rome III questionnaire in Korean. 
We have demonstrated that the Rome III-K is valid for diagnosis 
of FGIDs.
Many symptoms related to FGIDs, including pain with 
bowel habit change, early satiation and heartburn, are difficult to 
express clearly in Korean and can be easily misunderstood. 
Anatomical misunderstanding between the epigastrium and sub-
sternal area is one example. The Rome III-K contains a small il-
lustration to minimize such anatomical misunderstandings, and 
the satisfactory reliability shown by the test-retest method sug-
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gests that this questionnaire was translated accurately. However, 
the question “onset of pain associated with decreased frequency of 
stool” had poor reliability. This suboptimal result might be re-
lated to a lower positive response rate among patients. Cronbach’s 
α was also ＜ 0.6 for the question “epigastric pain not relieved by 
defecation.” It was not clear whether this poor reliability was re-
lated to significant overlap with IBS. A Portuguese validation of 
the Rome III questionnaire for FD showed a similar level of reli-
ability,11 whereas a Malay translation of the Rome III ques-
tionnaire for IBS had relatively higher test-retest reliability com-
pared with that in the present study.12
Convergent validity was excellent when we used the physi-
cian-completed questionnaire as the reference. The percent 
agreement between the physician-completed and self-ad-
ministered Rome III-K was ＞ 97% for all FGID items. FD 
showed excellent agreement at 97.9%; however, that between 
clinical diagnosis and self-reported ROME III-K decreased to 
66.0%. This reduction can be explained partly by the fact that the 
Rome III definition of FGIDs is stricter than physician’s clinical 
diagnosis. The Rome III criteria were developed for selecting 
pathogenetically homogenous patients for research.13 Therefore, 
strict definitions of symptom onset and duration were included. 
The major changes in the Rome III criteria compared to the 
Rome II criteria were symptom onset and duration; these were 
intended to decrease recall bias. Interestingly, the reliability of 
symptom onset and duration of each IBS and FD subscale had a 
Cronbach’s α coefficient ＞ 0.8 in the present study. Therefore, 
these questions may be important for discrimination of FGIDs 
from organic gastrointestinal symptoms. The clinical diagnosis of 
FD showed a marked discrepancy with the self-reported diag-
nosis, as 34.0% of the study population was diagnosed differently. 
However, this discrepancy was minimized to 2.1% when we in-
terviewed the participants and diagnosed FD based on the formal 
questionnaire. A questionnaire-based FD diagnosis may be far 
more accurate than a physician’s diagnosis for several reasons. 
The Rome III criteria for epigastric pain syndrome (EPS) are 
relatively strict, and a physician is more likely to fail to remember 
the criteria without a formal questioning form. Additionally, a 
marked overlap in non-erosive reflux disease with EPS was re-
ported recently in Korea, even though the authors used an in-
sufficiently validated questionnaire.14 Heartburn or acid regur-
gitation is the most bothersome symptom in only 24.6% of pa-
tients with reflux esophagitis, according to a nationwide endos-
copy-based study in Korea.15 More than 13% of patients with re-
flux esophagitis complained of epigastric pain as the most bother-
some symptom in that report. Therefore, it is difficult to dis-
tinguish FH from EPS according to the Rome III criteria in 
Koreans complaining of epigastric pain, and our data suggest a 
relatively low accuracy for the clinical diagnosis of FD. The 
Rome III-K contained only questions related to typical symp-
toms, heartburn and acid regurgitation, for the diagnosis of FH. 
In contrast, the absence of extraesophageal symptoms is the main 
disadvantage of the Rome III-K. Therefore, we developed ques-
tions regarding extraesophageal symptoms, including cough, 
asthma, globus pharyngitis, hoarseness and chest pain, to en-
hance the sensitivity of FH; however, these items have yet to be 
validated. These data confirm the convergent validity of the 
Rome III-K. The substantial degree of agreement with clinical 
diagnosis is comparable to questionnaires in other Asian langua-
ges.12
Discriminant validity is another pillar of construct validity, as 
introduced by Campbell.16 However, no standardized value is 
available for discriminant validity. In addition, it is theoretically 
difficult to validate when there is no previously validated tool that 
measures the same concept or disorder. Because the Rome III-K 
is the first systematically translated Korean questionnaire for di-
agnosis of FGIDs, we adopted a concurrent validation process. 
The previously validated SF-36-K can discriminate low HR-QOL 
in participants suffering from FGIDs. One report of a Korean pop-
ulation demonstrated that the HR-QOL is significantly impaired 
in subjects with IBS, uninvestigated dyspepsia and FH; this 
finding is consistent with data from other countries.10 Another 
study from Japan demonstrated worse HR-QOL in patients with 
an overlap of these 3 diseases.17 In the present study, almost all 
SF-36 domains were impaired in participants who were diag-
nosed with one of these FGIDs according to the Rome III-K. 
Furthermore, participants with overlapping disorders tended to 
reveal a worse QOL. These results suggest that the Rome III-K 
can discriminate the 2 groups of participants. The weakness of 
our study is the lack of demographic data regarding QOL (mar-
ital status, presence of religion, level of education, or economic 
status), which may be a confounder regarding discriminant 
validity.
We conclude that the Rome III-K questionnaire, developed 
using a structural translational process, had acceptable test-retest 
reliability and good construct validity. Nationwide epidemio-
logical studies and clinical trials should now be conducted using 
this first Korean instrument for diagnosis of FGIDs.
Validation of the Korean Rome III Questionnaire
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